A meta-analysis of 11 prospective studies investigating the associations between iron markers and breast cancer risk found a 22% increased risk associated with serum/plasma iron, but not for ferritin, transferrin saturation, or total iron-binding capacity (36). This evidence concerns the gene TF and breast carcinoma.